Expertise, Scale, and Trust in First-in-Human and Early Development At Aixial, we believe early phase trials—especially first-in-human (FIH) studies—set the…
Discuss our expertise in complex radiopharmaceutical trials at the 4th Targeted Radiopharmaceuticals Summit US in San Diego.
Discuss cutting-edge CNS research with our team at the 2025 SNO/ASCO CNS Metastases Conference.
Sarcomas are a diverse and rare group of malignant tumors arising from mesenchymal tissues, including bone, muscle, fat, and connective tissue.
Connect with our team to discuss biotech and life sciences collaboration in Philadelphia on September 4.
Meet our Business Development team, Sean Lambert and Shawn Cozad, to discuss your biotech needs.
Meet Aixial Group at COG: CRO Summit Europe in September in Amsterdam. Hear Managing Director Jonas Möller speak on efficient CRO solutions…
Discover our expertise in modernizing clinical trials for efficient research at the 15th Annual DPHARM in Philadelphia.
Discover our end-to-end clinical data management expertise at the 3rd Annual Clinical Data Management Innovation 2025.
Don’t miss our expert Jim Lincoln speak on rare disease trial expertise at the 3rd Annual Clinical Trials in Rare Diseases!
Discover Aixial Group’s Data Management expertise at SnB2025 in Paris, October 8-10. We offer end-to-end solutions for quality clinical trial data.
Brain tumours remain one of the most formidable challenges in medical science due to their complex biology, high morbidity, and limited treatment options.
